INDIANAPOLIS — Dangerous cold in the forecast has led a number of popular holiday activities in central Indiana to make changes. For our full list of closures and delays, follow this link. The ...

SAN ANTONIO — A 20-year-old woman is dead after losing control of her vehicle and crashing Saturday night, police say. SAPD was called to the 8900 block of US Highway 90 West around 7 p.m. for a major ...

Mobile carrier KT is facing mounting scrutiny after a government investigation found the company concealed a major malware infection last year. According to a joint government-private investigation ...

South Korea-based KT opened an innovation hub aimed at driving AI transformation (AX) among local businesses in partnership with Microsoft, building on an existing strategic alliance. The ...

The "Suddenly I See" singer-songwriter is currently working on songs for Clueless, the Hit Musical. By Gary Graff Would KT Tunstall like to be wearing Prada again? That, as they say in the film, is ...

KT has launched SOTA K built on GPT-4o, a Korean specialized artificial intelligence (AI) model developed in a strategic partnership with U.S. tech giant Microsoft. The new model will incorporate the ...

KT Corp reported a potential data breach to the South Korean authorities last week after its mobile network infrastructure was compromised Now it has confirmed the details and magnitude of that ...

PHOENIX--(BUSINESS WIRE)--Western Window Systems, part of the MITER Brands portfolio and a manufacturer of high-performance aluminum windows and doors for architects, builders, and homeowners, has ...

KT Corporation remains a buy with multiple positives. It is gaining market share in the Korean wireless industry at the expense of a key rival, judging by its favorable 2Q25 operating metrics. The ...

The Browns are second in waiver priority, but they decided not to wait to see if they could grab guard KT Leveston off waivers. Instead, the Browns have traded a 2028 seventh-round draft pick to the ...

Kymera Therapeutics said Sanofi has pulled the plug on the most advanced drug candidate in the companies' partnership aimed at immune-inflammatory diseases but plans to advance a second candidate into ...

Kymera's KT-621 shows promising STAT6 degradation in Phase 1 trials, with favorable safety and planned further studies in 2025. KT-621 demonstrated superior Th2 biomarker reductions compared to ...